Voluntary medical device correction: Freestyle Libre

Apr. 2023Important Notices
Abbott has initiated a voluntary medical device correction for readers that are used as part of the FreeStyle Libre, FreeStyle Libre 14 Day, and FreeStyle Libre 2 Flash glucose monitoring systems. These systems continuously measure the blood glucose levels of individuals with diabetes. Read more about the voluntary medical device correction for Freestyle Libre.

Recent Announcements

Medicaid provider update: High-cost Medicaid drug billing

Billing requirements for Medicaid-covered drugs
Dec. 2025Important Notices

CME Webinar: The State of Telehealth in 2026

Please join us for a live, CME-accredited webinar on Tuesday, Jan. 27, from noon to 1 p.m. that will share updates on the state of telehealth for 2026.
Dec. 2025Education/Webinars

Formulary updates effective Jan. 1, 2026

Review upcoming policy and operational updates
Dec. 2025Pharmacy Updates